EcoDrugPlus

Solute Carrier Family 6 Member 9

Ensembl ID : ENSCHAG00000020663
Gene Symbol: SLC6A9
1 Cross references
207 Possible Orthologues:

Solute Carrier Family 9 Member A3, Tandem Duplicate 2

Ensembl ID : ENSCHAG00000009668
Gene Symbol: SLC9A3.2
1 Cross references
238 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSCHAG00000013244
Gene Symbol: SSTR1
3 Cross references
160 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSCHAG00000000051
Gene Symbol: SSTR2
1 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSCHAG00000003798
Gene Symbol: SSTR2
1 Cross references
192 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSCHAG00000013311
Gene Symbol: SSTR4
3 Cross references
207 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSCHAG00000025282
Gene Symbol: S1PR1
3 Cross references
193 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSCHAG00000019937
Gene Symbol: SYK
1 Cross references
203 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSCHAG00000027725
Gene Symbol: LOC105911586
3 Cross references
211 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSCHAG00000014835
Gene Symbol: SRD5A2A
1 Cross references
208 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSCHAG00000014242
Gene Symbol: SOAT1
1 Cross references
211 Possible Orthologues:

Substance-P Receptor-Like

Ensembl ID : ENSCHAG00000020450
Gene Symbol: LOC105913302
3 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).